Similar articles for PMID: 22525514

Year	Number of Results
1995	1
1997	2
1998	1
2001	3
2002	1
2003	1
2004	1
2005	2
2006	6
2007	4
2008	3
2009	6
2010	6
2011	9
2012	15
2013	7
2014	10
2015	8
2016	7
2017	4
2018	6
2019	4
2020	9
2021	5
2022	11
2023	1
2024	0

1

In vivo gene delivery by nonviral vectors: overcoming hurdles?

Zhang Y, Satterlee A, Huang L. Zhang Y, et al. Mol Ther. 2012 Jul;20(7):1298-304. doi: 10.1038/mt.2012.79. Epub 2012 Apr 24. Mol Ther. 2012. PMID: 22525514 Free PMC article. Review.

2

Non-viral delivery of RNA interference targeting cancer cells in cancer gene therapy.

Huang PI, Lo WL, Cherng JY, Chien Y, Chiou GY, Chiou SH. Huang PI, et al. Curr Gene Ther. 2012 Aug;12(4):275-84. doi: 10.2174/156652312802083576. Curr Gene Ther. 2012. PMID: 22856602 Review.

3

Overcoming nonviral gene delivery barriers: perspective and future.

Jones CH, Chen CK, Ravikrishnan A, Rane S, Pfeifer BA. Jones CH, et al. Mol Pharm. 2013 Nov 4;10(11):4082-98. doi: 10.1021/mp400467x. Epub 2013 Oct 16. Mol Pharm. 2013. PMID: 24093932 Free PMC article.

4

Recent advances in nonviral vectors for gene delivery.

Guo X, Huang L. Guo X, et al. Acc Chem Res. 2012 Jul 17;45(7):971-9. doi: 10.1021/ar200151m. Epub 2011 Aug 26. Acc Chem Res. 2012. PMID: 21870813 Free PMC article.

5

Nonviral vectors in the new millennium: delivery barriers in gene transfer.

Nishikawa M, Huang L. Nishikawa M, et al. Hum Gene Ther. 2001 May 20;12(8):861-70. doi: 10.1089/104303401750195836. Hum Gene Ther. 2001. PMID: 11387052 Review.

6

Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration.

Zhou Z, Liu X, Zhu D, Wang Y, Zhang Z, Zhou X, Qiu N, Chen X, Shen Y. Zhou Z, et al. Adv Drug Deliv Rev. 2017 Jun 1;115:115-154. doi: 10.1016/j.addr.2017.07.021. Epub 2017 Aug 1. Adv Drug Deliv Rev. 2017. PMID: 28778715 Review.

7

In vivo delivery aspects of miRNA, shRNA and siRNA.

Khatri N, Rathi M, Baradia D, Trehan S, Misra A. Khatri N, et al. Crit Rev Ther Drug Carrier Syst. 2012;29(6):487-527. doi: 10.1615/critrevtherdrugcarriersyst.v29.i6.20. Crit Rev Ther Drug Carrier Syst. 2012. PMID: 23176057 Review.

8

Nonviral gene therapy.

Li S, Ma Z. Li S, et al. Curr Gene Ther. 2001 Jul;1(2):201-26. doi: 10.2174/1566523013348814. Curr Gene Ther. 2001. PMID: 12108955 Review.

9

Nanoparticle-based delivery system for application of siRNA in vivo.

Wang Y, Li Z, Han Y, Liang LH, Ji A. Wang Y, et al. Curr Drug Metab. 2010 Feb;11(2):182-96. doi: 10.2174/138920010791110863. Curr Drug Metab. 2010. PMID: 20359287 Review.

10

Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.

Shajari N, Mansoori B, Davudian S, Mohammadi A, Baradaran B. Shajari N, et al. Curr Drug Deliv. 2017;14(1):36-46. doi: 10.2174/1567201813666160816105408. Curr Drug Deliv. 2017. PMID: 27538460 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year